Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of Low FIB-4 in MASLD-Related Hepatocellular Carcinoma: A Multicentre Study.
Tan DJH, Tamaki N, Kim BK, Wijarnpreecha K, Aboona MB, Faulkner C, Kench C, Salimi S, Sabih AH, Lim WH, Danpanichkul P, Tay B, Teh Y, Mok J, Nah B, Ng CH, Muthiah M, Kulkarni AV, Lee SW, Liu K, Loomba R, Huang DQ; Global Liver Cancer Consortium. Tan DJH, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2024 Oct 27. doi: 10.1111/apt.18346. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39462858
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW, Yong JN, Tan DJH, Fu CE, Lim WH, Xiao J, Chan KE, Tan C, Goh XL, Chee D, Syn N, Tan EX, Muthiah MD, Ng CH, Tamaki N, Lee SW, Kim BK, Nguyen MH, Loomba R, Huang DQ. Zeng RW, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2023 Mar;57(6):600-609. doi: 10.1111/apt.17371. Epub 2023 Jan 10. Aliment Pharmacol Ther. 2023. PMID: 36625733 Free PMC article. Review.
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, Amangurbanova M, Siddiqi H, Madamba E, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Yoneda M, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. Lee SW, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2024 Jan;59(1):80-88. doi: 10.1111/apt.17783. Epub 2023 Nov 15. Aliment Pharmacol Ther. 2024. PMID: 37968251 Free PMC article.
Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis.
Tan DJH, Ng CH, Tay PWL, Syn N, Muthiah MD, Lim WH, Tang ASP, Lim KE, Lim GEH, Tamaki N, Kim BK, Teng MLP, Fung J, Loomba R, Nguyen MH, Huang DQ. Tan DJH, et al. Among authors: tamaki n. JAMA Netw Open. 2022 Jun 1;5(6):e2219407. doi: 10.1001/jamanetworkopen.2022.19407. JAMA Netw Open. 2022. PMID: 35767258 Free PMC article.
Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives.
Ng CH, Lim WH, Chin YH, Yong JN, Zeng RW, Chan KE, Tan DJH, Fu CE, Tang ASP, Goh LH, Devi K, Chew NWS, Mak LL, Tamaki N, Huang DQ, Noureddin M, Siddiqui MS, Loomba R, Sanyal AJ, Muthiah M. Ng CH, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2022 Aug;56(4):570-579. doi: 10.1111/apt.17121. Epub 2022 Jul 6. Aliment Pharmacol Ther. 2022. PMID: 35791632 Review.
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis.
Tan DJH, Quek SXZ, Yong JN, Suresh A, Koh KXM, Lim WH, Quek J, Tang A, Tan C, Nah B, Tan E, Keitoku T, Muthiah MD, Syn N, Ng CH, Kim BK, Tamaki N, Ho CSH, Loomba R, Huang DQ. Tan DJH, et al. Among authors: tamaki n. Clin Mol Hepatol. 2022 Oct;28(4):864-875. doi: 10.3350/cmh.2022.0136. Epub 2022 Jul 25. Clin Mol Hepatol. 2022. PMID: 36263668 Free PMC article.
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD.
Kim BK, Bernstein N, Huang DQ, Tamaki N, Imajo K, Yoneda M, Sutter N, Jung J, Nguyen K, Nguyen L, Le T, Madamba E, Richards L, Valasek MA, Behling C, Sirlin CB, Nakajima A, Loomba R. Kim BK, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2023 Jul;58(2):229-237. doi: 10.1111/apt.17564. Epub 2023 Jun 2. Aliment Pharmacol Ther. 2023. PMID: 37269117 Free PMC article.
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.
En Li Cho E, Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, Tan DJH, Lim WH, Yong JN, Zeng R, Chee D, Nah B, Lesmana CRA, Bwa AH, Win KM, Faulkner C, Aboona MB, Lim MC, Syn N, Kulkarni AV, Suzuki H, Takahashi H, Tamaki N, Wijarnpreecha K, Huang DQ, Muthiah M, Ng CH, Loomba R. En Li Cho E, et al. Among authors: tamaki n. Gut. 2023 Nov;72(11):2138-2148. doi: 10.1136/gutjnl-2023-330110. Epub 2023 Jul 25. Gut. 2023. PMID: 37491159
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses.
Noureddin N, Ajmera V, Bergstrom J, Bettencourt R, Huang DQ, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. Noureddin N, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2023 Nov;58(9):856-865. doi: 10.1111/apt.17707. Epub 2023 Sep 11. Aliment Pharmacol Ther. 2023. PMID: 37694993 Free PMC article.
1,579 results